Concepedia

Sara Esposite

SE

3

Publications

108

Citations

3

H-Index

2010

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sara Esposite is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2010–2010

3

Publications

3

Aurora Kinase Inhibitors Based on the Imidazo[1,2-<i>a</i>]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure

Angela D. Kerekes, Sara Esposite, Ronald J. Doll et al. · Journal of Medicinal Chemistry · 2010 · 57 citations · Full text

, , +15

Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-<i>a</i>]-Pyrazine Core

Tao Yu, Jayaram R. Tagat, Angela D. Kerekes et al. · ACS Medicinal Chemistry Letters · 2010 · 35 citations · Full text

, , +16

Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors

Zhaoyang Meng, Bheemashankar A. Kulkarni, Angela D. Kerekes et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 16 citations

, , +11

Rows per page

1–3 of 3